Hereditary renal cancer [12 genes]

Even though the majority of renal carcinomas are sporadic, there are hereditary syndromes that are associated to its predisposition, such as Von Hippel-Lindau syndrome (due to mutations in the VHL gene), Birt-Hogg-Dubé syndrome (FLCN gene), hereditary papillary renal cell carcinoma (MET gene), and hereditary leiomyomatosis associated with carcinoma of the renal cells (LH gene).

Request study Informed consent
Steps to follow
Steps to follow

How to order

1. Download & fill out

Please cover as many fields as possible in both documents

2. Sample collection

Three sample types: saliva, peripheral blood or genomic DNA

3. Pack the sample

Please pack the sample in a way to prevent leakage

4. Send the sample & the request

Please schedule the delivery for Mon–Thur: 8am – 5pm

5. Result: the report

Via: Client Site HIC / Client Site Imegen / Certified email

Ask for information
Solicita información de

Hereditary renal cancer

"*" indicates required fields

Consentimiento*
This field is for validation purposes and should be left unchanged.

Turnaround time (TAT): 4 weeks

Ref. S-202211926

Hereditary renal cancer: View panel

The genetic study can help carry out a correct differential diagnosis of the pathology and, therefore, not only guide the treatment but also provide a better prognosis approximation. Our recommendation includes a panel of multiple genes taking into account the different syndromes associated with both hereditary prostate cancer and hereditary renal cancer.

  • BAP1
  • FH
  • FLCN
  • MET
  • MITF
  • SDHA
  • SDHB
  • SDHC
  • SDHD
  • TSC1
  • TSC2
  • VHL

Priority Genes : Genes where there is sufficient evidence (clinical and functional) to consider them associated with the disease; they are included in the clinical practice guidelines.
Secondary Genes: Genes related to the disease, but with a lower level of evidence or that constitute sporadic cases.
* Candidate Genes: Not enough evidence in humans, but potentially associated with the disease.